BIOMAT Database Logo BIOMAT Database Logo

Lack of responsiveness to bromocriptine of Cushing's disease elevated ACTH. 1977

J L del Arbol, and A López-Luque, and J Jiménez, and F Escobar, and A Peña, and I Arcelus, and C Osorio

UI MeSH Term Description Entries
D006965 Hyperplasia An increase in the number of cells in a tissue or organ without tumor formation. It differs from HYPERTROPHY, which is an increase in bulk without an increase in the number of cells. Hyperplasias
D008236 Lypressin The porcine antidiuretic hormone (VASOPRESSINS). It is a cyclic nonapeptide that differs from ARG-VASOPRESSIN by one amino acid, containing a LYSINE at residue 8 instead of an ARGININE. Lys-vasopressin is used to treat DIABETES INSIPIDUS or to improve vasomotor tone and BLOOD PRESSURE. Lysine Vasopressin,Vasopressin, Lysine,8-Lysine Vasopressin,Diapid,Lys-Vasopressin,Lysyl Vasopressin,Postacton,8 Lysine Vasopressin,Lys Vasopressin,Vasopressin, 8-Lysine,Vasopressin, Lysyl
D001971 Bromocriptine A semisynthetic ergotamine alkaloid that is a dopamine D2 agonist. It suppresses prolactin secretion. 2-Bromoergocryptine,Bromocryptin,2-Bromo-alpha-ergocryptine,2-Bromo-alpha-ergokryptine,2-Bromoergocryptine Mesylate,2-Bromoergocryptine Methanesulfonate,2-Bromoergokryptine,Bromocriptin,Bromocriptine Mesylate,CB-154,Parlodel,2 Bromo alpha ergocryptine,2 Bromo alpha ergokryptine,2 Bromoergocryptine,2 Bromoergocryptine Mesylate,2 Bromoergocryptine Methanesulfonate,2 Bromoergokryptine,CB 154,CB154,Mesylate, 2-Bromoergocryptine,Mesylate, Bromocriptine,Methanesulfonate, 2-Bromoergocryptine
D003480 Cushing Syndrome A condition caused by prolonged exposure to excess levels of cortisol (HYDROCORTISONE) or other GLUCOCORTICOIDS from endogenous or exogenous sources. It is characterized by upper body OBESITY; OSTEOPOROSIS; HYPERTENSION; DIABETES MELLITUS; HIRSUTISM; AMENORRHEA; and excess body fluid. Endogenous Cushing syndrome or spontaneous hypercortisolism is divided into two groups, those due to an excess of ADRENOCORTICOTROPIN and those that are ACTH-independent. Cushing's Syndrome,Hypercortisolism,Syndrome, Cushing,Syndrome, Cushing's
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000304 Adrenal Cortex Function Tests Examinations that evaluate and monitor hormone production in the adrenal cortex.
D000311 Adrenal Glands A pair of glands located at the cranial pole of each of the two KIDNEYS. Each adrenal gland is composed of two distinct endocrine tissues with separate embryonic origins, the ADRENAL CORTEX producing STEROIDS and the ADRENAL MEDULLA producing NEUROTRANSMITTERS. Adrenal Gland,Gland, Adrenal,Glands, Adrenal
D000315 Adrenalectomy Excision of one or both adrenal glands. (From Dorland, 28th ed) Adrenalectomies
D000324 Adrenocorticotropic Hormone An anterior pituitary hormone that stimulates the ADRENAL CORTEX and its production of CORTICOSTEROIDS. ACTH is a 39-amino acid polypeptide of which the N-terminal 24-amino acid segment is identical in all species and contains the adrenocorticotrophic activity. Upon further tissue-specific processing, ACTH can yield ALPHA-MSH and corticotrophin-like intermediate lobe peptide (CLIP). ACTH,Adrenocorticotropin,Corticotropin,1-39 ACTH,ACTH (1-39),Adrenocorticotrophic Hormone,Corticotrophin,Corticotrophin (1-39),Corticotropin (1-39),Hormone, Adrenocorticotrophic,Hormone, Adrenocorticotropic

Related Publications

J L del Arbol, and A López-Luque, and J Jiménez, and F Escobar, and A Peña, and I Arcelus, and C Osorio
Lack of responsiveness to L-dopa in Cushing's disease.
February 1973, The Journal of clinical endocrinology and metabolism,
J L del Arbol, and A López-Luque, and J Jiménez, and F Escobar, and A Peña, and I Arcelus, and C Osorio
ACTH and cortisol response to bromocriptine, and results of long-term therapy, in Cushing's disease.
November 1978, Acta endocrinologica,
J L del Arbol, and A López-Luque, and J Jiménez, and F Escobar, and A Peña, and I Arcelus, and C Osorio
Bromocriptine for Cushing's disease.
April 1977, British medical journal,
J L del Arbol, and A López-Luque, and J Jiménez, and F Escobar, and A Peña, and I Arcelus, and C Osorio
Six year remission of ACTH-dependent Cushing's syndrome using bromocriptine.
March 1985, Postgraduate medical journal,
J L del Arbol, and A López-Luque, and J Jiménez, and F Escobar, and A Peña, and I Arcelus, and C Osorio
Lack of effect of bromocriptine on ACTH levels in patients with bilateral adrenalectomy for pituitary-dependent Cushing's syndrome.
October 1978, Journal of endocrinological investigation,
J L del Arbol, and A López-Luque, and J Jiménez, and F Escobar, and A Peña, and I Arcelus, and C Osorio
ACTH independent Cushing's disease.
May 1990, Journal of endocrinological investigation,
J L del Arbol, and A López-Luque, and J Jiménez, and F Escobar, and A Peña, and I Arcelus, and C Osorio
Cushing's disease: clinical and laboratory response to bromocriptine therapy.
December 1984, Journal of endocrinological investigation,
J L del Arbol, and A López-Luque, and J Jiménez, and F Escobar, and A Peña, and I Arcelus, and C Osorio
In vivo and in vitro studies in a patient with cyclical Cushing's disease showing some responsiveness to bromocriptine.
January 1991, Hormone research,
J L del Arbol, and A López-Luque, and J Jiménez, and F Escobar, and A Peña, and I Arcelus, and C Osorio
[ACTH producing adenoma (Cushing's disease)].
March 2011, Nihon rinsho. Japanese journal of clinical medicine,
J L del Arbol, and A López-Luque, and J Jiménez, and F Escobar, and A Peña, and I Arcelus, and C Osorio
Vasopressin responsiveness of subclinical Cushing's syndrome due to ACTH-independent macronodular adrenocortical hyperplasia.
February 2004, Clinical endocrinology,
Copied contents to your clipboard!